Virtual Human Delivered Nutrition Module for Colorectal Cancer Prevention

Colorectal Cancer Clinical Trial

Official title:

Adapting and Pilot Testing a Nutrition Module Delivered With Virtual Human Technology for Colorectal Cancer Prevention

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04192071
• Other study ID #: IRB202301722
• Secondary ID: 3R01CA207689-03S
• Status: Recruiting
• Phase: N/A
• Start date: January 6, 2020
• Est. completion date: January 31, 2024

Study information

• Verified date: September 2023
• Source: University of Florida
• Contact: Melissa Vilaro, PhD
• Phone: 352-273-3525
• Email: mgraveley[@]ufl.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study uses the opinions of adults between the ages of 45 and 73 years old to develop and test an interactive nutrition module for use in an existing colorectal cancer screening intervention using virtual human technology. This study will contribute to knowledge of what messages and graphics promote understanding of cancer risk and promote screening.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 180
• Est. completion date: January 31, 2024
• Est. primary completion date: January 31, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 45 Years to 73 Years

Eligibility

Inclusion Criteria:

• Eligible adults will be between 45 -73 years old,

• Proficient in English and

• Geographically residing in rural areas.

Exclusion:

-

Related Conditions & MeSH terms

• Colorectal Cancer
• Colorectal Neoplasms

Intervention

Other:
• virtual technology - high interactive
Participants engage with web-based cancer prevention content and answer a short series of questions designed to assess their baseline risk for colon cancer and dietary intake. Interactive nutrition risk feedback will be customized based on user input.
• virtual technology - low interactive
Participants engage with web-based cancer prevention content and answer a short series of questions designed to assess their baseline risk for colon cancer. Minimally interactive risk feedback will be delivered.
• non-colorectal cancer related module
Participants engage with web-based content not related to colorectal cancer or nutrition.

Locations

Country	Name	City	State
United States	University of Florida	Gainesville	Florida

Sponsors (2)

Lead Sponsor	Collaborator
University of Florida	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Risk perceptions for colorectal cancer	Items measured on a 10-point Likert scale, (e.g. "My chances of getting colorectal cancer are high")	up to 2 hours
Primary	Intentions to screen for colorectal cancer	Items measured on a 10-point Likert scale, (e.g. "I want to get screened for colorectal cancer")	up to 2 hours
Primary	Information seeking behavior	Does participant click on link to more information. The survey platforms event tracking feature will be used to track clicks (yes/no) for more information.	up to 2 hours